How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Background. Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) have been described as revolutionary. However, it remains uncertain how effective these drugs will be for individuals coinfected with human immunodeficiency virus (HIV)–HCV. Bridging this gap between efficacy and effectivene...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Saeed, Sahar, Strumpf, Erin C., Walmsley, Sharon L., Rollet-Kurhajec, Kathleen, Pick, Neora, Martel-Laferrière, Valerie, Hull, Mark, Gill, M. John, Cox, Joseph, Cooper, Curtis, Klein, Marina B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
HIV/AIDS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4787608/
https://ncbi.nlm.nih.gov/pubmed/26743093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ1222
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi